This paper medical the strength of that most of clinical show of safety and tolerability of flavoxate in Uronid symptomatic treatment of OAB. Flavoxate is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to flavoxate.
Possible side effects of Uronid include:
Uronid is used to treat diseases such as: Dysuria, Overactive Bladder, Urinary Incontinence.
The dose may be increased at 3 to 4 day intervals to 225 mg every 8 hours and, if needed, to 300 mg every 8 hours.